JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$2.05B |
| 2 |
iShares S&P 500 Growth ETF
IVW
|
+$1.92B |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.13B |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
+$1.1B |
| 5 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.24B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.12B |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$989M |
| 4 |
Microsoft
MSFT
|
+$973M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$931M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.54% |
| 2 | Technology | 14.97% |
| 3 | Healthcare | 10.91% |
| 4 | Financials | 10.87% |
| 5 | Consumer Discretionary | 8.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3376
PUT
CSX Corp
CSX
$87.8B
| $825K | ﹤0.01% |
43,200
-360,900
| -89% | -$8.43M |
2016 Q3
14 quarters
|
|
|
GRTS
3377
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $825K | ﹤0.01% |
141,886
+9,965
| +8% | +$83.7K |
2018 Q3
6 quarters
|
|
3378
CALL
Graphic Packaging
GPK
$2.56B
| $824K | ﹤0.01% |
+67,500
| New | +$994K |
2020 Q1
0 quarters
|
|
3379
iShares Global Consumer Staples ETF
KXI
$1.11B
| $824K | ﹤0.01% |
+17,244
| New | +$912K |
2020 Q1
0 quarters
|
|
|
MRTX
3380
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $824K | ﹤0.01% |
10,702
-6,510
| -38% | -$584K |
2018 Q2
7 quarters
|
|
3381
PUT
Apollo Global Management
APO
$68.4B
| $821K | ﹤0.01% |
+24,500
| New | +$1.05M |
2020 Q1
0 quarters
|
|
3382
iShares Core Conservative Allocation ETF
AOK
$822M
| $818K | ﹤0.01% |
24,229
+2,627
| +12% | +$93.6K |
2015 Q3
18 quarters
|
|
3383
Prospect Capital
PSEC
$1B
| $817K | ﹤0.01% |
192,141
-107,042
| -36% | -$632K |
2015 Q2
19 quarters
|
|
|
TSG
3384
PUT
DELISTED
The Stars Group Inc.
TSG
| $817K | ﹤0.01% |
+40,000
| New | +$900K |
2020 Q1
0 quarters
|
|
3385
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.1B
| $815K | ﹤0.01% |
28,286
+1,086
| +4% | +$37.9K |
2016 Q1
16 quarters
|
|
3386
CALL
Spotify
SPOT
$100B
| $814K | ﹤0.01% |
+6,700
| New | +$948K |
2020 Q1
0 quarters
|
|
3387
Standex International
SXI
$3.55B
| $808K | ﹤0.01% |
16,513
-9,203
| -36% | -$604K |
2013 Q2
27 quarters
|
|
3388
Merit Medical Systems
MMSI
$5.1B
| $807K | ﹤0.01% |
25,827
-1,047
| -4% | -$37.3K |
2016 Q2
15 quarters
|
|
|
RWUI
3389
DELISTED
Direxion FTSE Russell US Over International ETF
RWUI
| $807K | ﹤0.01% |
+15,596
| New | +$954K |
2020 Q1
0 quarters
|
|
|
KEM
3390
DELISTED
KEMET Corporation
KEM
| $804K | ﹤0.01% |
33,299
-1,826,636
| -98% | -$46.4M |
2017 Q2
11 quarters
|
|
3391
Astronics
ATRO
$2.88B
| $803K | ﹤0.01% |
104,945
+80,941
| +337% | +$1.46M |
2017 Q4
9 quarters
|
|
|
EIDX
3392
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $803K | ﹤0.01% |
16,392
+11,435
| +231% | +$583K |
2018 Q3
6 quarters
|
|
|
VMW
3393
CALL
DELISTED
VMware, Inc
VMW
| $799K | ﹤0.01% |
6,600
-38,900
| -85% | -$5.35M |
2019 Q1
4 quarters
|
|
|
ISBC
3394
CALL
DELISTED
Investors Bancorp, Inc.
ISBC
| $799K | ﹤0.01% |
100,000
| – | – |
2019 Q4
1 quarter
|
|
|
SBBP
3395
DELISTED
Strongbridge Biopharma plc.
SBBP
| $799K | ﹤0.01% |
422,711
+354,945
| +524% | +$923K |
2019 Q2
3 quarters
|
|
3396
FB Financial Corp
FBK
$2.64B
| $796K | ﹤0.01% |
40,338
+28,605
| +244% | +$915K |
2016 Q4
13 quarters
|
|
3397
State Street SPDR S&P Regional Banking ETF
KRE
$3.67B
| $796K | ﹤0.01% |
24,406
-7,526
| -24% | -$368K |
2013 Q2
27 quarters
|
|
3398
Citizens & Northern Corp
CZNC
$459M
| $795K | ﹤0.01% |
39,708
-2,825
| -7% | -$68.6K |
2013 Q2
27 quarters
|
|
3399
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
$1.34B
| $795K | ﹤0.01% |
15,531
-17,834
| -53% | -$1.15M |
2017 Q4
9 quarters
|
|
3400
SiriusXM
SIRI
$8.82B
| $795K | ﹤0.01% |
16,092
-108,806
| -87% | -$7.12M |
2013 Q2
27 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2020 Portfolio in Review
As of Q1 2020, JP Morgan Chase held 6,012 positions worth $426B, down 21% from $536B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase deployed $14B of net new capital in Q1 2020, opening 362 new positions and adding to 2,382 existing holdings. Its largest new stake was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
By sector, the portfolio is most concentrated in Miscellaneous at 28% of assets, down from 28% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was JPMorgan BetaBuilders Japan ETF, an estimated $1.24B trimmed.
- JP Morgan Chase's largest Q1 2020 buy was NextEra Energy, Inc. 5.279% Corporate Units: 1,245,017 shares worth $54.9M.
- JP Morgan Chase added most to iShares S&P 500 Value ETF in Q1 2020, an estimated $2.05B increase.
- JP Morgan Chase's biggest Q1 2020 reduction was JPMorgan BetaBuilders Japan ETF, cutting an estimated $1.24B.
- JP Morgan Chase fully exited Liberty Property Trust in Q1 2020, selling an estimated $264M.
- JP Morgan Chase's ten largest holdings make up 18% of its $426B portfolio in Q1 2020.
- JP Morgan Chase opened 362 new positions and closed 692 in Q1 2020.
- JP Morgan Chase's portfolio value fell 21% quarter-over-quarter to $426B.
Based on JP Morgan Chase's 13F filing for Q1 2020, filed 12 May 2020.